Literature DB >> 18493273

Autoregulation, a balancing act between supply and demand.

Josef Flammer1, Maneli Mozaffarieh.   

Abstract

Regulation of blood flow is necessary to adapt to different conditions. Regulation of ocular blood flow (OBF) compensates for varying perfusion pressures (autoregulation), adapts to the retinal activity (neurovascular coupling), and keeps the back of the eye at constant temperature (thermoregulation). While all vessels are under the control of the vascular endothelial cells, the retinal vessels are additionally under the control of the neural and glial cells, and the choroidal vessels are influenced by the autonomic nervous system. The optic nerve head is additionally controlled by circulating hormones. If the regulation does not occur according to the needs of the tissue, it is referred to as vascular dysregulation. Such a dysregulation can be secondary in nature, as, for example, in multiple sclerosis, in which the high level of endothelin reduces OBF. Dysregulation, however, can also occur without any underlying disease and is characterized by an inborn tendency to respond differently to various stimuli, such as cold temperatures or mechanical or emotional stress. The constellation of these features is known as primary vascular dysregulation (PVD). Subjects with PVD have disturbed autoregulation leading to an unstable OBF. This instability, in turn, induces a repeated mild reperfusion injury. The resulting oxidative stress contributes to the pathogenesis of glaucomatous optic neuropathy.

Entities:  

Mesh:

Year:  2008        PMID: 18493273     DOI: 10.3129/i08-056

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  59 in total

Review 1.  Cellular and physiological mechanisms underlying blood flow regulation in the retina and choroid in health and disease.

Authors:  Joanna Kur; Eric A Newman; Tailoi Chan-Ling
Journal:  Prog Retin Eye Res       Date:  2012-05-03       Impact factor: 21.198

2.  Thermal discomfort with cold extremities in relation to age, gender, and body mass index in a random sample of a Swiss urban population.

Authors:  Maneli Mozaffarieh; Paola Fontana Gasio; Andreas Schötzau; Selim Orgül; Josef Flammer; Kurt Kräuchi
Journal:  Popul Health Metr       Date:  2010-06-04

Review 3.  Endothelin antagonism as an active principle for glaucoma therapy.

Authors:  Rita Rosenthal; Michael Fromm
Journal:  Br J Pharmacol       Date:  2011-02       Impact factor: 8.739

4.  OCTA vessel density changes in the macular zone in glaucomatous eyes.

Authors:  C Lommatzsch; K Rothaus; J M Koch; C Heinz; S Grisanti
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2018-04-10       Impact factor: 3.117

5.  Candidate genes for chromosomes 6 and 10 quantitative trait loci for age-related retinal degeneration in mice.

Authors:  Diego G Ogando; Kam D Dahlquist; Mitra Alizadeh; Kannan Kunchithapautham; Jun Li; Nicole Yu; Matthew M LaVail; Bärbel Rohrer; Douglas Vollrath; Michael Danciger
Journal:  Mol Vis       Date:  2010-06-05       Impact factor: 2.367

6.  Unusual morphologies of blood eosinophils in GM-CSF-producing lung cancer.

Authors:  Y Izumiya; Y Okuda; S Ueki; M Takeda; K Sato; K Nakayama
Journal:  QJM       Date:  2021-02-18

Review 7.  Angiotensin II-related hypertension and eye diseases.

Authors:  Pablo Jesus Marin Garcia; Maria Encarna Marin-Castaño
Journal:  World J Cardiol       Date:  2014-09-26

8.  Arterial spin labeling fMRI measurements of decreased blood flow in primary visual cortex correlates with decreased visual function in human glaucoma.

Authors:  Robert O Duncan; Pamela A Sample; Christopher Bowd; Robert N Weinreb; Linda M Zangwill
Journal:  Vision Res       Date:  2012-03-29       Impact factor: 1.886

9.  Retinal blood flow in glaucomatous eyes with single-hemifield damage.

Authors:  Mitra Sehi; Iman Goharian; Ranjith Konduru; Ou Tan; Sowmya Srinivas; Srinivas R Sadda; Brian A Francis; David Huang; David S Greenfield
Journal:  Ophthalmology       Date:  2013-11-28       Impact factor: 12.079

Review 10.  Hypoxia-inducible factor-1 (HIF-1): a potential target for intervention in ocular neovascular diseases.

Authors:  Ramya Krishna Vadlapatla; Aswani Dutt Vadlapudi; Ashim K Mitra
Journal:  Curr Drug Targets       Date:  2013-07       Impact factor: 3.465

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.